Independent Director · Cullinan Therapeutics, Inc. (CGEM)

Anthony Rosenberg director compensation at Cullinan (FY2025): $306K

Fiscal year 2025 director compensation for Anthony Rosenberg at Cullinan Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Anthony Rosenberg’s full pay file as a PDF — free

More than this page: up to 10 years of Anthony’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Anthony Rosenberg and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Cullinan Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Cullinan Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$91,334$0$214,995$0$306,329
FY2023$93,250—$164,452$27,133$284,835
FY2021$86,500—$147,888$0$234,388

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-183465, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cullinan Therapeutics, Inc. filed document, accession 0001193125-26-183465. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Cullinan Therapeutics Board Governance Report

$306,329 Anthony Rosenberg, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Cullinan Therapeutics pays directors a $40,000 cash retainer and $215,000 in Options.

Committees

FY2025 · as the proxy prints them

Audit

The rest of the Cullinan Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Andrew Allen, M.D., Ph.DIndependent Director$377,326
David MeekIndependent Director$268,639
Mary ThistleIndependent Director$49,781
Mittie Doyle, M.D., FACRIndependent Director$376,928
Nadim AhmedDirector—
Stephen WebsterIndependent Director$283,186

The full Cullinan Therapeutics compensation record

free company brief

This page is one director within Cullinan Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order CGEM

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report